Biotechnology company developing RNA nanomedicines and mRNA therapeutics for rare inherited diseases, particularly life-threatening liver diseases and urea cycle disorders in children
Biotechnology company developing RNA nanomedicines and mRNA therapeutics for rare inherited diseases, particularly life-threatening liver diseases and urea cycle disorders in children. Its proprietary SMARTT Polymer Technology is designed to deliver mRNA effectively with a favorable side-effect profile and scalable manufacturing.